Literature DB >> 30992797

The epidemiology of nonalcoholic steatohepatitis.

Zobair M Younossi1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30992797      PMCID： PMC6385947          DOI： 10.1002/cld.710

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  22 in total

1.  Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis.

Authors:  Noha F Hassan; Somaia A Nada; Azza Hassan; Mona R El-Ansary; Muhammad Y Al-Shorbagy; Rania M Abdelsalam
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 2.  Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations.

Authors:  Solène Marie; David K K Tripp; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2021-09-16       Impact factor: 3.579

3.  PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample.

Authors:  Trang VoPham; Nicole J Kim; Kristin Berry; Jason A Mendoza; Joel D Kaufman; George N Ioannou
Journal:  Environ Res       Date:  2022-06-07       Impact factor: 8.431

4.  The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD.

Authors:  Jin Zhou; Rohit A Sinha; Paul M Yen
Journal:  Hepatoma Res       Date:  2021-11-05

5.  Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.

Authors:  Marc Puigvehí; Dana Hashim; Philipp K Haber; Amreen Dinani; Thomas D Schiano; Amon Asgharpour; Tatyana Kushner; Gaurav Kakked; Parissa Tabrizian; Myron Schwartz; Ahmet Gurakar; Douglas Dieterich; Paolo Boffetta; Scott L Friedman; Josep M Llovet; Behnam Saberi
Journal:  Am J Transplant       Date:  2019-10-11       Impact factor: 8.086

6.  NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.

Authors:  Jiyoon Park; Eunice Yewon Lee; Jie Li; Mi Jung Jun; Eileen Yoon; Sang Bong Ahn; Chuanli Liu; Hongli Yang; Fajuan Rui; Biyao Zou; Linda Henry; Dong Hyun Lee; Dae Won Jun; Ramsey C Cheung; Mindie H Nguyen
Journal:  Dig Dis       Date:  2021-02-03       Impact factor: 2.404

7.  Magnesium intake is associated with a reduced risk of incident liver cancer, based on an analysis of the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study prospective cohort.

Authors:  Shailja C Shah; Xiangzhu Zhu; Qi Dai; Richard M Peek; Martha J Shrubsole
Journal:  Am J Clin Nutr       Date:  2021-03-11       Impact factor: 7.045

8.  Soy Isoflavones Improve the Spermatogenic Defects in Diet-Induced Obesity Rats through Nrf2/HO-1 Pathway.

Authors:  Qihui Luo; Yifan Li; Chao Huang; Dongjing Cheng; Wenjing Ma; Yu Xia; Wentao Liu; Zhengli Chen
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

9.  Modelling NAFLD disease burden in four Asian regions-2019-2030.

Authors:  Chris Estes; Henry L Y Chan; Rong N Chien; Wan-Long Chuang; James Fung; George Boon-Bee Goh; Tsung H Hu; Jee-Fu Huang; Byoung K Jang; Dae W Jun; Jia H Kao; Jin-Woo Lee; Han-Chieh Lin; Kathryn Razavi-Shearer; Wai-Kay Seto; Grace L-H Wong; Vincent W-S Wong; Homie Razavi
Journal:  Aliment Pharmacol Ther       Date:  2020-03-04       Impact factor: 8.171

10.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.